. Expression of Concern: Relative Effectiveness and Waning of a Third Dose of mRNA COVID-19 Vaccine in Medicare Beneficiaries Aged 65 Years and Older during the BA.1/BA.2 Omicron Period. J Infect Dis 2024 Nov 28:jiae549. doi: 10.1093.
PMID: 39607799